申请人:Boehringer Ingelheim GmbH
公开号:US03937708A1
公开(公告)日:1976-02-10
Compounds of the formula ##SPC1## Wherein R is hydrogen, halogen, lower alkyl or lower alkoxy, R' is --CHR.sub.1 --Q--A, --CHR.sub.2 --A or --O--CHR.sub.2 --CHR.sub.1 --Q--A, each in m- or p-position, Where A is ##SPC2## Q is straight or branched alkylene of 1 to 4 carbon atoms, R.sub.1 is hydrogen, hydroxyl, lower alkoxy or --O--CO--R.sub.5, R.sub.2 is hydrogen or methyl, R.sub.3 and R.sub.4, which may be identical to or different from each other, are each hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl or, together with each other and neighboring carbon atoms of the phenyl ring to which they are attached, form a saturated or unsaturated carbocyclic 5- to 6-membered ring, R.sub.5 is lower alkyl, halo-lower alkyl, hydroxy-lower alkyl, lower alkoxy-lower alkyl, amino, (mono-lower alkyl)-amino or (di-lower alkyl)-amino, Z is an aromatic heterocyclic ring with one to two heteroatoms, which may optionally be condensed with a benzene ring, and R" is hydrogen, straight or branched lower alkyl, lower alkenyl, lower alkynyl, hydroxy-lower alkyl, (di-lower alkyl)-amino-lower alkyl or aralkyl, And their non-toxic, pharmacologically acceptable acid addition salts; the compounds as well as their salts are useful as CNS-depressants, neuroleptics, analgesics, antiphlogistics, spasmolytics, broncholytics, hypotensives and anti-cholesteremics.
式为##SPC1##的化合物,其中R为氢、卤素、较低的烷基或较低的烷氧基,R'为--CHR.sub.1 --Q--A、--CHR.sub.2 --A或--O--CHR.sub.2 --CHR.sub.1 --Q--A,每个在m-或p-位置,其中A为##SPC2##,Q为1至4个碳原子的直链或支链烷基,R.sub.1为氢、羟基、较低的烷氧基或--O--CO--R.sub.5,R.sub.2为氢或甲基,R.sub.3和R.sub.4,它们可以相同也可以不同,每个为氢、较低的烷基、较低的烷氧基、卤素、三氟甲基或与它们相邻的苯环碳原子一起形成饱和或不饱和的碳环5至6元环,R.sub.5为较低的烷基、卤代较低的烷基、羟基较低的烷基、较低的烷氧基较低的烷基、氨基、(单较低的烷基)-氨基或(二较低的烷基)-氨基,Z为含有一到两个杂原子的芳香杂环,可以选择性地与苯环融合,R"为氢、直链或支链较低的烷基、较低的烯基、较低的炔基、羟基较低的烷基、(二较低的烷基)-氨基较低的烷基或芳基烷基,以及它们的无毒、药理学上可接受的酸盐;这些化合物及其盐可用作中枢神经系统抑制剂、神经阻滞剂、镇痛剂、抗炎药、解痉药、支气管扩张剂、降压药和抗胆固醇药。